Imagion Biosystems Limited (IBXXF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -11.74 Million AUD | -17.68% |
| 2022 | -9.8 Million AUD | -62.87% |
| 2021 | -6.02 Million AUD | -12.37% |
| 2020 | -5.35 Million AUD | -56.5% |
| 2019 | -3.42 Million AUD | 58.91% |
| 2018 | -8.33 Million AUD | -21.47% |
| 2017 | -6.85 Million AUD | -0.89% |
| 2016 | -6.79 Million AUD | -64.82% |
| 2015 | -4.12 Million AUD | -77.84% |
| 2014 | -2.31 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 FY | -11.53 Million AUD | -17.68% |
| 2023 Q2 | -3.61 Million AUD | 0.0% |
| 2023 Q1 | -3.61 Million AUD | -82.61% |
| 2023 Q4 | -2.26 Million AUD | 0.0% |
| 2023 Q3 | -2.26 Million AUD | 37.45% |
| 2022 Q4 | -1.97 Million AUD | 0.0% |
| 2022 FY | -9.8 Million AUD | -62.87% |
| 2022 Q3 | -1.97 Million AUD | 30.26% |
| 2022 Q2 | -2.83 Million AUD | 0.0% |
| 2022 Q1 | -2.83 Million AUD | -24.17% |
| 2021 Q3 | -2.28 Million AUD | -216.22% |
| 2021 Q4 | -2.28 Million AUD | 0.0% |
| 2021 FY | -6.02 Million AUD | -12.37% |
| 2021 Q2 | -722.56 Thousand AUD | 0.0% |
| 2021 Q1 | -722.56 Thousand AUD | 59.47% |
| 2020 Q1 | -846.81 Thousand AUD | 41.97% |
| 2020 Q2 | -846.81 Thousand AUD | 0.0% |
| 2020 Q4 | -1.78 Million AUD | 0.0% |
| 2020 FY | -5.35 Million AUD | -56.5% |
| 2020 Q3 | -1.78 Million AUD | -110.51% |
| 2019 Q1 | -235.94 Thousand AUD | 91.17% |
| 2019 FY | -3.42 Million AUD | 58.91% |
| 2019 Q3 | -1.45 Million AUD | -518.51% |
| 2019 Q2 | -235.94 Thousand AUD | 0.0% |
| 2019 Q4 | -1.45 Million AUD | 0.0% |
| 2018 Q2 | -1.71 Million AUD | 0.0% |
| 2018 FY | -8.33 Million AUD | -21.47% |
| 2018 Q3 | -2.67 Million AUD | -55.64% |
| 2018 Q1 | -1.71 Million AUD | 31.27% |
| 2018 Q4 | -2.67 Million AUD | 0.0% |
| 2017 FY | -6.85 Million AUD | -0.89% |
| 2017 Q3 | -2.49 Million AUD | -168.13% |
| 2017 Q4 | -2.49 Million AUD | 0.0% |
| 2017 Q2 | -931.57 Thousand AUD | 0.0% |
| 2017 Q1 | -931.57 Thousand AUD | 0.0% |
| 2016 FY | -6.79 Million AUD | -64.82% |
| 2015 FY | -4.12 Million AUD | -77.84% |
| 2014 FY | -2.31 Million AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -845.809% |
| Arrayit Corporation | -3.62 Million USD | -224.276% |
| Atlantic International Corp. | -5.73 Million USD | -104.918% |
| Biocept, Inc. | -31.98 Million USD | 63.271% |
| Bioqual, Inc. | -19.63 Thousand USD | -59717.405% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -1421.345% |
| DermTech, Inc. | -103.73 Million USD | 88.676% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.472% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 43.605% |
| iMD Companies, Inc. | -175.44 Thousand USD | -6595.474% |
| IDenta Corp. | -1499.00 USD | -783551.901% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 518.935% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 30461.701% |
| InVitro International | -25.33 Thousand USD | -46259.138% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | -64.939% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -20114.314% |
| Medical Imaging Corp. | -819.48 Thousand USD | -1333.463% |
| NovelStem International Corp. | -3.52 Million USD | -233.171% |
| Optigenex Inc. | 1.39 Million USD | 944.596% |
| PharmChem, Inc. | 973.14 Thousand USD | 1307.109% |
| Proteome Sciences plc | -1.62 Million USD | -624.673% |
| Response Genetics, Inc | -21.37 Million USD | 45.049% |
| Rennova Health, Inc. | -1.4 Million USD | -733.392% |
| RushNet, Inc. | -684.7 Thousand USD | -1615.621% |
| ScreenPro Security Inc. | -2.59 Million USD | -353.125% |
| Stella Diagnostics Inc. | -11.42 Million USD | -2.8% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | -51.637% |
| Todos Medical Ltd. | -9.74 Million USD | -20.506% |